Prelude Therapeutics Statistics

Total Valuation

PRLD has a market cap or net worth of $61.09 million. The enterprise value is -$71.10 million.

Market Cap	61.09M
Enterprise Value	-71.10M

Important Dates

The next estimated earnings date is Thursday, February 13, 2025, after market close.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	n/a

Share Statistics

PRLD has 55.04 million shares outstanding. The number of shares has increased by 35.27% in one year.

Current Share Class	42.18M
Shares Outstanding	55.04M
Shares Change (YoY)	+35.27%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	6.35%
Owned by Institutions (%)	21.35%
Float	13.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.95
Forward PS	n/a
PB Ratio	0.41
P/TBV Ratio	0.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.04, with a Debt / Equity ratio of 0.12.

Current Ratio	7.04
Quick Ratio	6.91
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.64% and return on invested capital (ROIC) is -43.33%.

Return on Equity (ROE)	-66.64%
Return on Assets (ROA)	-39.29%
Return on Invested Capital (ROIC)	-43.33%
Return on Capital Employed (ROCE)	-81.87%
Revenue Per Employee	$23,438
Profits Per Employee	-$1.03M
Employee Count	128
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.16% in the last 52 weeks. The beta is 1.36, so PRLD's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	-62.16%
50-Day Moving Average	1.09
200-Day Moving Average	2.97
Relative Strength Index (RSI)	47.75
Average Volume (20 Days)	224,644

Short Selling Information

The latest short interest is 3.12 million, so 5.66% of the outstanding shares have been sold short.

Short Interest	3.12M
Short Previous Month	3.38M
Short % of Shares Out	5.66%
Short % of Float	22.44%
Short Ratio (days to cover)	4.53

Income Statement

In the last 12 months, PRLD had revenue of $3.00 million and -$131.52 million in losses. Loss per share was -$1.77.

Revenue	3.00M
Gross Profit	3.00M
Operating Income	-143.26M
Pretax Income	-129.85M
Net Income	-131.52M
EBITDA	-141.65M
EBIT	-143.26M
Loss Per Share	-$1.77

Full Income Statement

Balance Sheet

The company has $153.63 million in cash and $18.14 million in debt, giving a net cash position of $135.49 million or $2.46 per share.

Cash & Cash Equivalents	153.63M
Total Debt	18.14M
Net Cash	135.49M
Net Cash Per Share	$2.46
Equity (Book Value)	156.43M
Book Value Per Share	2.84
Working Capital	134.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$105.72 million and capital expenditures -$1.84 million, giving a free cash flow of -$107.56 million.

Operating Cash Flow	-105.72M
Capital Expenditures	-1.84M
Free Cash Flow	-107.56M
FCF Per Share	-$1.95

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-4,775.40%
Pretax Margin	-4,383.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PRLD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.27%
Shareholder Yield	-35.27%
Earnings Yield	-204.25%
FCF Yield	-167.04%

Analyst Forecast

The average price target for PRLD is $4.50, which is 305.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	305.41%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-13.66%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PRLD has an Altman Z-Score of -2.27 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.27
Piotroski F-Score	1